Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1

Oncogene

Volumn 28, Issue 42, 2009, Pages 3702-3713

  Zheng, H Q ^a   Zhou, Z ^a   Huang, J ^b   Chaudhury, L ^a   Dong, J T ^c   Chen, C ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; FGF BP; KLF5; Proliferation; Transcription factor

Indexed keywords

BINDING PROTEIN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1; KRUPPEL LIKE FACTOR 5; LUCIFERASE; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CELL; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HEK293; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GC RICH SEQUENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; UP-REGULATION;

MUS MUSCULUS;

EID: 70350575752     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.235     Document Type: Article

References (45)

1. Abuharbeid S, Czubayko F, Aigner A. (2006). The fibroblast growth factor-binding protein FGF-BP. Int J Biochem Cell Biol 38: 1463-1468.
2. Aigner A, Butscheid M, Kunkel P, Krause E, Lamszus K, Wellstein A et al. (2001). An FGF-binding protein (FGF-BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 release. Int J Cancer 92: 510-517.
3. Aizawa K, Suzuki T, Kada N, Ishihara A, Kawai-Kowase K, Matsumura T et al. (2004). Regulation of platelet-derived growth factor-A chain by Kruppel-like factor 5: new pathway of cooperative activation with nuclear factor-kappaB. J Biol Chem 279: 70-76.
4. Bateman NW, Tan D, Pestell RG, Black JD, Black AR. (2004). Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem 279: 12093-12101.
5. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A et al. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
6. Chanchevalap S, Nandan MO, McConnell BB, Charrier L, Merlin D, Katz JP et al. (2006). Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res 34: 1216-1223.
7. Chen C, Benjamin MS, Sun X, Otto KB, Guo P, Dong XY et al. (2006). KLF5 promotes cell proliferation and tumorigenesis through gene regulation in the TSU-Pr1 human bladder cancer cell line. Int J Cancer 118: 1346-1355.
8. Chen C, Bhalala HV, Qiao H, Dong JT. (2002). A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21: 6567-6572.
9. Chen C, Sun X, Guo P, Dong XY, Sethi P, Cheng X et al. (2005a). Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J Biol Chem 280: 41553-41561.
10. Chen C, Sun X, Guo P, Dong XY, Sethi P, Zhou W et al. (2007a). Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer. Oncogene 26: 2386-2394.
11. Chen C, Sun X, Ran Q, Wilkinson KD, Murphy TJ, Simons JW et al. (2005b). Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene 24: 3319-3327.
12. Chen C, Zhou Z, Ross JS, Zhou W, Dong JT. (2007b). The amplified WWP1 gene is a potential molecular target in breast cancer. Int J Cancer 121: 2834-2841.
13. Czubayko F, Liaudet-Coopman ED, Aigner A, Tuveson AT, Berchem GJ, Wellstein A. (1997). A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat Med 3: 1137-1140.
14. Czubayko F, Riegel AT, Wellstein A. (1994a). Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth. J Biol Chem 269: 21358-21363.
15. Czubayko F, Smith RV, Chung HC, Wellstein A. (1994b). Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem 269: 28243-28248.
16. Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, Nishimura G et al. (2005). Synthetic retinoid Am80 suppresses smooth muscle pheno-typic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res 97: 1132-1141.
17. Harris VK, Kagan BL, Ray R, Coticchia CM, Liaudet-Coopman ED, Wellstein A et al. (2001). Serum induction of the fibroblast growth factor-binding protein (FGF-BP) is mediated through ERK and p38 MAP kinase activation and C/EBP-regulated transcription. Oncogene 20: 1730-1738.
18. Harris VK, Liaudet-Coopman ED, Boyle BJ, Wellstein A, Riegel AT. (1998). Phorbol ester-induced transcription of a fibroblast growth factor-binding protein is modulated by a complex interplay of positive and negative regulatory promoter elements. J Biol Chem 273: 19130-19139.
19. Kagan BL, Henke RT, Cabal-Manzano R, Stoica GE, Nguyen Q, Wellstein A et al. (2003). Complex regulation of the fibroblast growth factor-binding protein in MDA-MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Cancer Res 63: 1696-1705.
20. Kojima S, Kobayashi A, Gotoh O, Ohkuma Y, Fujii-Kuriyama Y, Sogawa K. (1997). Transcriptional activation domain of human BTEB2, a GC box-binding factor. J Biochem (Tokyo) 121: 389-396.
21. Kurtz A, Aigner A, Cabal-Manzano RH, Butler RE, Hood DR, Sessions RB et al. (2004). Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing. Neoplasia 6: 595-602.
22. Kurtz A, Wang HL, Darwiche N, Harris V, Wellstein A. (1997). Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis. Oncogene 14: 2671-2681.
23. Kwak MK, Lee HJ, Hur K, Park do J, Lee HS, Kim WH et al. (2008). Expression of Kruppel-like factor 5 in human gastric carcinomas. J Cancer Res Clin Oncol 134: 163-167.
24. Li WM, Chen WB. (2004). Effect of FGF-BP on angiogenesis in squamous cell carcinoma. Chin Med J (Engl) 117: 621-623.
25. McConnell BB, Ghaleb AM, Nandan MO, Yang VW. (2007). The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29: 549-557.
26. Mohsin SK, Weiss H, Havighurst T, Clark GM, Berardo M, Roanh le D et al. (2004). Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol 17: 1545-1554.
27. Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, Fujiu K et al. (2005). Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab 1: 27-39.
28. Ray PE, Tassi E, Liu XH, Wellstein A. (2006). Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-asso-ciated hemolytic uremic syndrome. Am J Physiol Regul Integr Comp Physiol 290: R105-R113.
29. Ray R, Cabal-Manzano R, Moser AR, Waldman T, Zipper LM, Aigner A et al. (2003). Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesis. Cancer Res 63: 8085-8089.
30. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC et al. (2002). Active genes are tri-methylated at K4 of histone H3. Nature 419: 407-411.
31. Shi H, Zhang Z, Wang X, Liu S, Teng CT. (1999). Isolation and characterization of a gene encoding human Kruppel-like factor 5 (IKLF): binding to the CAAT/GT box of the mouse lactoferrin gene promoter. Nucleic Acids Res 27: 4807-4815.
32. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S et al. (2002). Kruppel-like zinc-finger transcription factor KLF5/ BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 8: 856-863.
33. Sogawa K, Imataka H, Yamasaki Y, Kusume H, Abe H, Fujii-Kuriyama Y. (1993). cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucleic Acids Res 21: 1527-1532.
34. Sun R, Chen X, Yang VW. (2001). Intestinal-enriched Kruppel-like factor (Kruppel-like factor 5) is a positive regulator of cellular proliferation. J Biol Chem 276: 6897-6900.
35. Sur I, Rozell B, Jaks V, Bergstrom A, Toftgard R. (2006). Epidermal and craniofacial defects in mice overexpressing Klf5 in the basal layer of the epidermis. J Cell Sci 119: 3593-3601.
36. Sur I, Unden AB, Toftgard R. (2002). Human Kruppel-like factor5/KLF5: synergy with NF-kappaB/Rel factors and expression in human skin and hair follicles. Eur J Cell Biol 81: 323-334.
37. Tassi E, Henke RT, Bowden ET, Swift MR, Kodack DP, Kuo AH et al. (2006). Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. Cancer Res 66: 1191-1198.
38. Tong D, Czerwenka K, Heinze G, Ryffel M, Schuster E, Witt A et al. (2006). Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin Cancer Res 12: 2442-2448.
39. Wan H, Luo F, Wert SE, Zhang L, Xu Y, Ikegami M et al. (2008). Kruppel-like factor 5 is required for perinatal lung morphogenesis and function. Development 135: 2563-2572.
40. Wang X, Zhao J. (2007). KLF8 transcription factor participates in oncogenic transformation. Oncogene 26: 456-461.
41. Wu DQ, Kan MK, Sato GH, Okamoto T, Sato JD. (1991). Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J Biol Chem 266: 16778-16785.
42. Yang Y, Goldstein BG, Chao HH, Katz JP. (2005). KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther 4: 1216-1221.
43. Yang Y, Goldstein BG, Nakagawa H, Katz JP. (2006). Kruppel-like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells. FASEB J 21: 543-550.
44. Zhang Z, Teng CT. (2003). Phosphorylation of Kruppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its trans-activation function. Nucleic Acids Res 31: 2196-2208.
45. Zhao Y, Hamza MS, Leong HS, Lim CB, Pan YF, Cheung E et al. (2008). Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells. Oncogene 27: 1-8.